Yazar "Şengül, Aysun" için Tıp Fakültesi Koleksiyonu listeleme
-
Characteristics of our hypoxemic COVID-19 pneumonia patients receiving corticosteroids and mortality-associated factors
Şengül, Aysun; Mutlu, Pınar; Özdemir, Özer; Satıcı, Celal; Turan, Muzaffer Onur; Arslan, Sertaç; Mirici, Arzu; Mutlu, Levent Cern; Fazlioglu, Nevin (Taylor & Francis Ltd, 2022)Background COVID-19 is a disease associated with diffuse lung injury that has no proven effective treatment yet. It is thought that glucocorticoids may reduce inflammation-mediated lung injury, disease progression, and ... -
Desquamative interstitial pneumonia: Risk factors, laboratory and bronchoalveolar lavage findings, radiological and histopathological examination, clinical features, treatment and prognosis
Diken, Özlem Ercen; Şengül, Aysun; Beyan, Ayse Coskun; Ayten, Omer; Mutlu, Levent Cem; Okutan, Oguzhan (Spandidos Publ Ltd, 2019)Desquamative interstitial pneumonia is a type of smoking-associated major idiopathic interstitial pneumonia, which is characterized by accumulation of alveolar macrophages in alveolar lumens and septa and develops secondary ... -
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Şengül, Aysun; Aydemir, Yusuf; Özaydın, Derya; Kabalak, Pınar Akın; Söyler, Yasemin; Baykal, Hüsnü; Mutlu, Pınar (European Respiratory Soc Journals Ltd, 2021)[No Abstract Available] -
Protective Effect of Infliximab, a Tumor Necrosis Factor-Alfa Inhibitor, on Bleomycin-Induced Lung Fibrosis in Rats
Altıntaş, Nejat; Erboğa, Mustafa; Aktaş, Cevat; Bilir, Bülent; Aydın, Murat; Şengül, Aysun; Gürel, Ahmet; Topçu, Birol (Springer/Plenum Publishers, 2016)We aimed to investigate the preventive effect of Infliximab (IFX), a tumor necrosis factor (TNF)-alpha inhibitor, on bleomycin (BLC)-induced lung fibrosis in rats. Rats were assigned into four groups as follows: I-BLC ...